Use Of Compulsory Licensing ‘More Frequent Than Commonly Assumed’

 
• By Ian Schofield
  
Access
The use of the TRIPS provisions to increase medicines access is greater than generally assumed.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet